;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • BioPorto Diagnostics diagnostic news

    BioPorto Diagnostics A/S (CSE:BIOPOR), Gentofte, Denmark Business: Diagnostic BioPorto said the European Patent Office ruled that BioPorto's European Patent No. EP1831699 doesn't meet the "requirements for adequate …

    Published on 4/7/2014
  • Celgene, Mylan cancer, generics news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Cancer, Generics Mylan filed a suit in the U.S. District Court for the District of New Jersey alleging that Celgene is …

    Published on 4/7/2014
  • Celltrion, Hospira, J&J, Nippon Kayaku autoimmune, biosimilars news

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Nippon Kayaku Co. Ltd. (Tokyo:4272), Tokyo, Japan Business: Autoimmune, …

    Published on 4/7/2014
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline will invest 25 million ($41.6 million) to create an R&D Open Lab facility for non-communicable diseases in Africa to allow …

    Published on 4/7/2014
  • Hospira, Medicines Co. cardiovascular news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. The Medicines Co. (NASDAQ:MDCO), Parsippany, N.J. Business: Cardiovascular A judge in the U.S. District Court for the District of Delaware found that two of The Medicines Co.'s…

    Published on 4/7/2014
  • New York Genome Center (NYGC), University of Buffalo genomics news

    New York Genome Center (NYGC), New York, N.Y. University of Buffalo, Buffalo, N.Y. Business: Genomics The New York State legislature approved Gov. Andrew Cuomo's 2014-15 budget, which allocates $105 million in funding …

    Published on 4/7/2014
  • NIH, Northwestern University, Parkinson Study Group, The Michael J. Fox Foundation for Parkinson's Research (MJFF) neurology news

    National Institutes of Health, Bethesda, Md. Northwestern University, Evanston, Ill. Parkinson Study Group, Boston, Mass. The Michael J. Fox Foundation for Parkinson's Research (MJFF), New York, N.Y. Business: Neurology…

    Published on 4/7/2014
  • NovaDel neurology news

    NovaDel Pharma Inc. (Pink:NVDL), Bridgewater, N.J. Business: Neurology NovaDel said it will submit a recommendation to shareholders to dissolve the company and liquidate its assets. Pending shareholder approval and the …

    Published on 4/7/2014
  • Oculus, Ruthigen dermatology news

    Oculus Innovative Sciences Inc. (NASDAQ:OCLS), Petaluma, Calif. Ruthigen Inc. (NASDAQ:RTGN), Santa Rosa, Calif. Business: Dermatology Oculus said that it made modifications to its corporate governance following the IPO …

    Published on 4/7/2014
  • Pernix Therapeutics, Woodfield Pharmaceutical LLC supply/service news

    Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), The Woodlands, Texas Woodfield Pharmaceutical LLC, Boca Raton, Fla. Business: Supply/Service Pernix will divest its Houston manufacturing facility to Woodfield for about $…

    Published on 4/7/2014
  • Pulmokine, NIH cardiovascular news

    Pulmokine Inc., Rensselaer, N.Y. National Institutes of Health, Bethesda, Md. Business: Cardiovascular Pulmokine received a contract worth up to $1.5 million from NIH's National Heart, Lung, and Blood Institute (NHLBI) …

    Published on 4/7/2014
  • Sorrento veterinary, cancer news

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Veterinary, Cancer Sorrento formed a subsidiary, Ark Animal Therapeutics, to develop therapies for animal health applications. The subsidiary's …

    Published on 4/7/2014
  • Southwest Research Institute (SwRI), U.S. Department of Health and Human Services other news

    Southwest Research Institute (SwRI), San Antonio, Texas U.S. Department of Health and Human Services, Washington, D.C. Business: Other The not-for-profit said HHS's Biomedical Advanced Research and Development Authority…

    Published on 4/7/2014
  • Teva autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune The U.S. Supreme Court agreed to hear Teva's appeal of an appeals court ruling that will end exclusivity for the biotech's …

    Published on 4/7/2014
  • Viiv Healthcare, Medicines Patent Pool infectious news

    ViiV Healthcare Ltd., Brentford, U.K. Medicines Patent Pool, Geneva, Switzerland Business: Infectious ViiV granted the Medicines Patent Pool licenses to develop, manufacture and supply HIV drug Tivicay dolutegravir. …

    Published on 4/7/2014
  • Actavis, Hisamitsu neurology news

    Actavis plc (NYSE:ACT), Dublin, Ireland Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Business: Neurology Hisamitsu's Noven Pharmaceuticals Inc. subsidiary granted Actavis a non-exclusive, royalty-bearing …

    Published on 3/31/2014
  • AstraZeneca pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pharmaceuticals AstraZeneca launched its Open Innovation website, which lists programs available for partnering and invites proposals for further development. …

    Published on 3/31/2014
  • Baxter pharmaceuticals, biosimilars news

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals, Biosimilars Baxter said it will split its medical products and biopharmaceuticals businesses into two public companies. The pharma said …

    Published on 3/31/2014
  • Emergent BioSolutions, Mapp Biopharmaceutical, Zalgen Labs LLC, Ben-Gurion University of the Negev, NIH, Public Health Agency of Canada, Scripps Research Institute, Uganda Virus Research Institute ...

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. Mapp Biopharmaceutical Inc., San Diego, Calif. Zalgen Labs LLC, Germantown, Md. Ben-Gurion University of the Negev, Beer-Sheva, Israel National Institutes of Health,…

    Published on 3/31/2014
  • Gilead, Idenix infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Cambridge, Mass. Business: Infectious Idenix said the Oslo, Norway District Court ruled that Idenix's Norwegian Patent …

    Published on 3/31/2014
  • GlaxoSmithKline, European Bioinformatics Institute of the European Molecular Biology Laboratory (EMBL-EBI), Wellcome Trust Sanger Institute functional genomics news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. European Bioinformatics Institute of the European Molecular Biology Laboratory (EMBL-EBI), Hinxton, U.K. Wellcome Trust Sanger Institute, Hinxton, U.K. Business: …

    Published on 3/31/2014
  • IntegraGen, Gustave Roussy Institute pharmacogenetics, genomics news

    IntegraGen S.A. (Euronext:ALINT), Evry, France Gustave Roussy Institute, Villejuif, France Business: Pharmacogenetics, Genomics Next quarter, IntegraGen will install and operate on behalf of the institute a high …

    Published on 3/31/2014
  • J&J neurology news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Neurology The Arkansas Supreme Court reversed and remanded a 2012 lower court ruling, which fined Johnson & Johnson $1.2 billion for violating state fraud …

    Published on 3/31/2014
  • Jubilant Life Sciences, Infectious Disease Research Institute (IDRI), Bill & Melinda Gates Foundation infectious news

    Jubilant Life Sciences Ltd. (BSE:530019; NSE:JUBILANT), Noida, India Infectious Disease Research Institute (IDRI), Seattle, Wash. Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious IDRI received a $3.4…

    Published on 3/31/2014
  • Mylan, GlaxoSmithKline neurology news

    Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Neurology In Mylan Inc. et al v. SmithKline Beecham Corp. et al, a jury in the U.S. District Court for the …

    Published on 3/31/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993